Eleva initiates patient dosing in phase 1 study of Factor H programme in C3-Glomerulopathy

Join Pharma | Login

	Editorial


	STILL A TOOTHLESS TIGER
	Tuesday, July 1, 2025
	Unethical marketing practices by the pharmaceutical companies have been a major issue the country has been facing for a long time now.
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	Eleva initiates patient dosing in phase 1 study of Factor H programme in C3-Glomerulopathy
17:00 [IST]	Sirtex Medical’s SIR-Spheres Y-90 resin microspheres receive US FDA nod to treat unresectable hepatocellular carcinoma
16:00 [IST]	Elekta & Gray partner to offer optimized oncology appointment scheduling for Elekta ONE OIS customers
15:45 [IST]	DevsHealth and FNDR unveil the first fully AI-designed antiviral compound targeting dengue
15:00 [IST]	US FDA accepts for review Berkshire Biomedical’s De Novo application for marketing authorization of COPA System
14:45 [IST]	Bharat Serums and Mankind Pharma call for caution from snake bites during monsoons

more news >>

TOP NEWS


08:00 [IST]	NPPA notifies retail prices of 71 formulations
08:00 [IST]	DoC reviews, discusses key issues with stakeholders in exports, imports, trade data and regulations
08:00 [IST]	FOPE president asks MSMEs to implement revised Schedule M as govt unlikely to extend deadline
08:00 [IST]	NPPA notifies separate retail price of GSK's cold medicine
08:00 [IST]	India and Uzbekistan eye strategic pharma collaboration to strengthen bilateral trade
08:00 [IST]	DCC gives nod to amend Rules related to licensing of stem cell derived & gene therapy products

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Akeso enrols first patient in phase Ia trial for AK146D1, a bispecific ADC targeting Trop2 and Nectin4
17:00 [IST]	Biosynth expands Berlin site with a new commercial bioconjugation suite
16:30 [IST]	Karnataka FDA Belagavi, BDR&WPA along with JITO Belgaum, hold awareness rally on drug abuse
16:10 [IST]	CBI alleges criminal misconduct, exchange of bribe in the acts of PCI president and others: say reports
16:00 [IST]	Brii Bio ink licensing pact with Joincare Group for research, development & commercialization of BRII-693 in Greater China
15:30 [IST]	WIKA India unveils ‘Re-Inventing Hygiene’ campaign to advance standards in pharma instrumentation

more news >>

INTERVIEW


Telangana State’s pharma future hinges on strategic collaboration between industry, academia & government: KV Rambabu
KV Rambabu, president of Telangana State board of Indian Drug Manufacturers Association

Past Interviews...

	What's New?

AI minimises risks associated with med documentation Technology disrupts Indian lab equipment landscape Healthcare landscape undergoing dramatic shift PharmaTech Expo to drive growth and competitiveness Formulations industry going from strength to strength

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers